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One-Year Unadjusted and Adjusted Hazard Ratios for Adverse Events in
Patients Stratiﬁed by Smoking Status
Smokers
(n¼9,299)
Non-
smokers
(n¼21,570)
Unadjusted
HR [95% CI] p-value
Adjusted
HR
[95% CI] p-value
Death 222 (2.6) 621 (3.3) 0.83
[0.72,0.97]
0.02 1.71
[1.44,
2.04]
<0.0001
Cardiac death 133 (1.5) 378 (2.0) 0.82
[0.67,1.00]
0.05 1.55
[1.24,
1.95]
0.0001
Myocardial
reinfarction
492 (5.5) 1077 (5.2) 1.06
[0.96,1.18]
0.25 1.19
[1.06,
1.35]
0.005
Target vessel
revascularization
622 (7.3) 1517 (7.4) 0.96
[0.88,1.06]
0.41 0.93
[0.84,
1.03]
0.16
Deﬁnite/
probable stent
169 (1.9) 193 (1.0) 2.05
[1.67,2.52]
<0.0001 2.05
[1.65,
<0.0001
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Background: Percutaneous coronary intervention (PCI) of calciﬁed lesions has been
shown tobeassociatedwithworse ischemicoutcomes in several studies. These studieswere
limited by a high rate of bare-metal stents and drug-eluting stents (DES) of ﬁrst generation
use, and infrequent usage of intra-vascular ultrasound (IVUS) for PCI optimization. We
sought to determine the frequency and impact of coronary calciﬁcation (CCA) among
patientsundergoingPCI in the contemporarydrug-eluting stent erawith frequent IVUSuse.
Methods: ADAPT-DES was a prospective, multicenter registry of patients success-
fully treated with one or more drug-eluting stents. Patients were stratiﬁed and 1-year
outcomes compared according to the presence of CCA (per site operator assessment)
of the target lesion.
Results: Among8,578patientswhounderwent PCI inADAPT-DES,CCAwaspresent in
2646/8578 (30.8%) patients. IVUSwas used in 3349 (39.0%) patients of the entire cohort.
CCAwas more frequent in advanced age, hyperlipidaemia, hypertension, history of renal
insufﬁciency, presence of multi-vessel disease, low white blood cell count, and IVUS
guided-PCI. The unadjusted 1-year rate of death, myocardial infarction (MI), ischemic
target vessel revascularization (TVR), and major adverse cardiac events (MACE) were
signiﬁcantly increased in patients with presence of CCA (Table). By multivariable anal-
ysis, also adjusting for IVUS use, the presence of CCA was an independent predictor of
1-year ischemia-driven TVR (HR [95%CI] 1.20 [1.00, 1.45], p¼0.05), myocardial
infarction (HR 1.77 [1.37, 2.27], p< 0.0001), death-MI (HR 1.66 [1.35, 2.04], p< 0.0001)
and MACE (HR¼1.41 [1.19, 1.68] p< 0.0001). No signiﬁcant interaction was detected
between the presence of CCA, IVUS use, and all ischemic outcomes.
Conclusions: CCA was associated with worse outcomes after DES PCI despite high
rate of IVUS usage.Table. One-year Outcomes According to the Presence of Coronary
Calciﬁcation
Calciﬁed lesions
(N¼2646)
Non-calciﬁed Lesions
(N¼5932)
P-value
Death 2.6% (69) 1.6% (92) 0.002
Cardiovascular 1.5% (40) 1.1% (60) 0.06
Death/MI 7.0% (184) 3.8% (220) <0.0001
Myocardial infarction 4.7% (124) 2.5% (145) <0.0001
Ischemia-driven TVR 7.2% (191) 5.5% (325) 0.002
ST deﬁnite/probable 0.9% (24) 0.8% (46) 0.58
Major adverse
cardiac events
8.9% (233) 5.9% (337) <0.0001
Major adverse cardiac events is a composite of cardiac death, myocardial infarction or target
lesion revascularization; TVR¼target vessel revascularization; ST¼stent thrombosis
thrombosis 2.54]
Major adverse
cardiac events
1116 (12.8) 2762 (13.5) 0.94
[0.88,1.01]
0.10 1.06
[0.97,
1.15]
0.19
Data presented as n (%); Major adverse cardiac events include death, reinfarction and target
vessel revascularization.
Variables included in multivariable analysis: age, male, diabetes, hyperlipidemia, hyperten-
sion, prior myocardial infarction, prior PCI, prior coronary artery bypass graft surgery, number
of stents, number of vessels treated, and smokingTCT-110
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Background: Available data on relationship between smoking status and outcomes
among patients (pts) undergoing percutaneous coronary intervention (PCI) are con-
ﬂicting. We sought to further clarify this relationship.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/AngioplasMethods: Patient-level pooled data from 18 prospective randomized trials (RAVEL,
E-SIRIUS, SIRIUS, C-SIRIUS, TAXUS I-II, TAXUS IV-VI, ENDEAVOR II-IV,
SPIRIT II-IV, ACUITY, HORIZONS-AMI and COMPARE) were pooled. Pts were
stratiﬁed by their current smoking status prior to randomization. One-year ischemic
outcomes were compared between the 2 groups.
Results: Among the 30,869-pooled pts, 9,299 (30.1%) were actively smoking before
PCI. At baseline, smokers were younger, less likely to have diabetes, dyslipidaemia,
prior MI, PCI or CABG. Angiographically, they had less complex (severe calciﬁca-
tions or tortuosity) and less extensive CAD at baseline. At 1 year, smokers had lower
unadjusted rates of death and cardiac death. However, after adjustment for potential
cofounders, smoking status at baseline was identiﬁed as a strong independent pre-
dictor of all ischemic endpoints at 1 year, including death, cardiac death, and stent
thrombosis (Table).
Conclusions: Results from this large pooled analysis of pts undergoing PCI
demonstrated that the “smoker’s paradox” represents a statistical artefact, most
likely related to the lack of adjustment for potential cofounders. Smoking remains
an important predictor of poor outcomes after PCI and should be strongly
discouraged.TCT-111
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Background: HIV is associated with premature coronary artery disease (CAD) and
increased risk of adverse events. It has been shown that women have higher morbidity
than men in this setting, perhaps due to the young age of this population. However,
little is known about the sex-based differences angiographic pattern or burden of CAD
in this population.
Methods: We followed 93 consecutive patients with HIV who underwent PCI from
2003 to 2011 at our center. Quantitative coronary angiographic (QCA) analysis wasty Overview and Outcomes B33
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comperformed independently for all treated lesions. We compared QCA and major adverse
cardiac events (MACE) including death, myocardial infarction, and revascularization,
in male and female patients.
Results: Among 93 patients, 72 patients (77%) were male and 21 were female (23%).
The mean age was 56 years. Men had lower baseline ejection fraction and HDL
compared to women. Women were more likely to be African-American and to present
with unstable angina. On QCA, men had marginally worse CAD burden (SYNTAX
score of 13.8  8.2 vs.10.8  5.5, p¼0.08). QCA in women and men are shown in the
table (lesion-level analysis). 1 year MACE (21% vs. 28%, p¼ 0.71) was similar in
men and women.Table. Angiographic characteristics according to gender (lesion-level
analysis)
Male (n ¼
110)
Females (n ¼
30)
P
value
Lesion length (mm) 17.1  11.3 16.8  9.7 0.91
RVD (mm) 2.68  0.71 2.5  0.65 0.23
MLD (mm) 0.87  0.53 0.92  0.45 0.64
Diameter stenosis (%) 68  15.5 63  14 0.12
Lesion location
LAD 58 (52.7%) 21 (71.4%) 0.19
LCx 47 (43%) 3 (9%) 0.005
RCA 40 (36%) 14 (47.6%) 0.34
Proximal (vs mid, distal) 30 (27%) 5 (16.7%) 0.51
Heavy calciﬁcation (vs no/mild,
moderate)
22 (21%) 3 (10%) 0.19
TIMI ﬂow grade 3 (vs 0, 1, 2) 79 (73.2%) 25 (86.2%) 0.43
True Bifurcation (x,x,1) 13 (11.9%) 5 (16.7%) 0.49
* p values for >2 groups comparisons (comparison groups listed). Abbreviations; LAD: Left
Anterior descending artery; LCx: Left circumﬂex artery; RCA: Right coronary arteryConclusions: In this ﬁrst, QCA based, HIV and gender analysis, male patients had
numerically worse CAD burden with respect to SYNTAX score, proximal disease and
calciﬁcation, none of which was statistically different. The MACE rate after PCI in
HIV patients was high irrespective of gender. Large prospective studies are required to
explore whether true differential sex-related effects on atherosclerosis development
and progression exist in patients with HIV.
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Background: Hospital readmission after percutaneous coronary intervention (PCI)
has emerged as an important quality metric for post-PCI care. There are limited data
examining the impact of race/ethnicity on 30-days post-PCI readmission.
Methods: We performed a single center study of 3368 consecutive patients under-
going PCI at our center. Race/ethnicity was self-reported as Caucasian, African
American, Hispanic and South Asian. Differences in baseline characteristics, 30-day
all cause readmission and clinical outcomes were examined.
Results: Compared to Caucasians (n¼1605, 48%), South Asians (n¼507, 15%) were
younger, more often male and diabetic while African-Americans (n¼401, 12%) were
more likely to be smokers and have higher serum creatinine and cholesterol levels.
Thirty day outcomes (death, MI, revascularization) were similar among groups
whereas 30 day all cause readmission was almost twofold higher in African-Ameri-
cans compared to other racial groups (Figure). Associations were unchanged after
multivariable adjustment, including insurance status.B34 JACC Vol 64/11/Suppl B j SeptembConclusions: In this single center registry, important baseline differences in clinical
characteristics were noted among racial groups undergoing PCI. While clinical out-
comes did not vary, African-American race was associated with an independent and
increased risk for 30-day readmission.
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Background: Estimating percutaneous coronary intervention (PCI) mortality risk by a
clinical prediction model is imperative to help physicians, patients and family mem-
bers make informed clinical decisions and optimize participation in the consent pro-
cess, reducing anxiety and improving quality of care. At a healthcare system level, risk
prediction scores are essential to measure and benchmark performance. We aimed to
assess the accuracy of the simple, contemporary and well-designed Toronto PCI
mortality risk score in ICP-BR registry, the ﬁrst Brazilian PCI multicenter registry
with follow-up information.
Methods: Between 2009 and 2013, a cohort of 4,806 patients from the ICP-BR
registry, treated with PCI in eight tertiary referral medical centers, was included in the
analysis. This population was compared to 10,694 patients of the derivation dataset
from the Toronto study. To assess predictive performance, an update of the model was
performed by three different methods, which were compared by discrimination,
calculating the area under the receiver operating characteristic curve (AUC), and by
calibration, assessed through Hosmer-Lemeshow (H-L) test and graphical analysis.
The score included the following predictors: age, diabetes, renal failure, NYHA class
IV heart failure symptoms, severe myocardial dysfunction, multivessel disease, left
main disease, recent myocardial infarction, early PCI after thrombolysis, primary PCI,
cardiogenic shock. In order to turn this risk stratiﬁcation more practical and simple, we
sought to divide the integer score according to the predictive risk in low (< 1%),
moderate (1-5%) and high (>5%) risk groups.
Results: Death occurred in 2.6% of patients in the ICP-BR registry and in 1.3% in the
Toronto cohort. The median age was 64 and 63 years, 23.8 and 32.8% were female,
28.6 and 32.3% were diabetics, respectively. Through recalibration of intercept and
slope (AUC¼ 0.8790; H-L p value¼ 0.3132), we achieved a well-calibrated and well-
discriminative model.
Conclusions: After updating to our dataset, we demonstrated that the Toronto PCI in-
hospital mortality risk score has a good performance and discrimination in Brazilian
hospitals.er 13–17, 2014 j TCT Abstracts/Angioplasty Overview and Outcomes
